Non-alcoholic fatty pancreas disease

Area of Science:

• Metabolic disorders and obesity research
• Gastroenterology and hepatology
• Endocrinology

Background:

• Obesity is a global health crisis linked to numerous diseases.
• Non-alcoholic fatty liver disease is well-studied, but pancreatic fat infiltration is emerging.
• Non-alcoholic fatty pancreas disease (NAFPD) is increasingly recognized as a significant comorbidity of obesity.

Purpose of the Study:

• To highlight the growing importance of investigating non-alcoholic fatty pancreas disease (NAFPD).
• To underscore the associations between NAFPD and other obesity-related conditions.
• To emphasize the need for detailed research into NAFPD's role in metabolic dysfunction and disease progression.

Main Methods:

• Review of current scientific literature on NAFPD.
• Analysis of the progression of pancreatic changes in obesity.
• Synthesis of findings linking NAFPD to other metabolic and malignant conditions.

Main Results:

• NAFPD develops as obesity progresses, following initial pancreatic hypertrophy and hyperplasia.
• NAFPD is associated with increased severity of acute pancreatitis.
• NAFPD is linked to pancreatic dysfunction in insulin resistance and type 2 diabetes mellitus (T2DM).

Conclusions:

• NAFPD is a significant consequence of obesity with broad clinical implications.
• NAFPD may contribute to the development of pancreatic carcinoma.
• Further detailed investigation into NAFPD is crucial for understanding and managing obesity-related diseases.